Capital Llc Greenland A Llc... Net Worth

The estimated Net Worth of Capital Llc Greenland A Llc... is at least 6.55 百万$ dollars as of 11 June 2021. Capital Llc owns over 66,396 units of Pmv Pharmaceuticals Inc stock worth over 191,919$ and over the last 3 years Capital sold PMVP stock worth over 6,357,662$.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Capital Llc PMVP stock SEC Form 4 insiders trading

Capital has made over 3 trades of the Pmv Pharmaceuticals Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently Capital sold 66,396 units of PMVP stock worth 2,258,128$ on 11 June 2021.

The largest trade Capital's ever made was selling 66,396 units of Pmv Pharmaceuticals Inc stock on 11 June 2021 worth over 2,258,128$. On average, Capital trades about 63,037 units every 1 days since 2021. As of 11 June 2021 Capital still owns at least 127,099 units of Pmv Pharmaceuticals Inc stock.

You can see the complete history of Capital Llc stock trades at the bottom of the page.

Insiders trading at Pmv Pharmaceuticals Inc

Over the last 4 years, insiders at Pmv Pharmaceuticals Inc have traded over 56,359,813$ worth of Pmv Pharmaceuticals Inc stock and bought 3,910,000 units worth 70,380,000$ . The most active insiders traders include Peter A. Thompson、Capital Management, L.P.Kol...、Thilo Schroeder. On average, Pmv Pharmaceuticals Inc executives and independent directors trade stock every 16 days with the average trade being worth of 130,810$. The most recent stock trade was executed by Advisors Llc Orbi Med Capit... on 22 November 2023, trading 87,786 units of PMVP stock currently worth 195,763$.

What does Pmv Pharmaceuticals Inc do?

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing mutant p53 programs, including Wild-type p53 Induced-Phosphatase, R282W, and R273H, as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.

Complete history of Capital Llc stock trades at Pmv Pharmaceuticals Inc

Pmv Pharmaceuticals Inc executives and stock owners

Pmv Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

• Dr. David H. Mack Ph.D.,
  Co-Founder, CEO, Pres & Director
• Winston Kung M.B.A.,
  COO & CFO
• Dr. Leila Alland M.D.,
  Chief Medical Officer
• Winston Kung,
  COO & CFO
• Dr. Arnold J. Levine Ph.D.,
  Co-Founder, Independent Director & Member of Scientific Advisory Board
• Melissa Dumble Ph.D.,
  Sr. VP of Preclinical Devel. & Translational Science
• Dr. Deepika Jalota Pharm.D.,
  Chief Regulatory & Quality Assurance Officer
• Dr. Binh Vu Ph.D.,
  Sr. VP of Drug Discovery & CMC
• Tim Smith,
  Sr. VP & Head of Corp. Devel.
• Robert Ticktin,
  Gen. Counsel & Company Sec.
• Dr. Thomas E. Shenk Ph.D.,
  Co-Founder & Member of Scientific Advisory Board
• Thilo Schroeder,
  Director
• Deepika Jalota,
  Chief Development Officer
• Capital Management, L.P.Kol...,
  
• Arnold L Oronsky,
  Director
• Partners X Lp Inter West Ma...,
  
• Peter A. Thompson,
  Director
• Advisors Llc Orbi Med Capit...,
  
• Samantha Dawson,
  
• Capital, Llc Boxer Asset Ma...,
  
• Alison Levine,
  
• Epiphany, Llc Double,
  
• Capital Llc Greenland A Llc...,
  
• Biomedical Innovation Maste...,
  
• V Oncology S.C.S., Sicav Si...,
  
• Laurie Stelzer,
  
• Capital Llc Greenland A Llc...,
  
• Winston Kung,
  COO, CFO
• Richard A. Heyman,
  
• David Henry Mack,
  President and CEO
• Charles M Baum,
  
• Leila Alland,
  Chief Medical Officer
• Kirsten Flowers,
  
• Michael Carulli,
  Chief Financial Officer
• Advisors Llc Orbi Med Capit...,
  
• Carol Giltner Gallagher,
  
• Arnold J Levine,